Senti Biosciences reported earnings of per SNTI share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.21 |
| Last Year's EPS | -$ 0.80 |
| EPS YoY Change |
Out of the last 24 earnings reporting periods, Senti Biosciences beat analysts’ expectations 8 times and fell short of expectations 6 time(s). Senti Biosciences reported earnings per share of in the last report surpassing an estimated EPS of -$ 0.21 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.21 | -$ 0.56 | - | |
| Aug 14, 2026 | -$ 0.27 | -$ 0.41 | -$ 1.41 | |
| May 14, 2026 | -$ 0.27 | -$ 0.14 | -$ 0.67 | |
| Mar 27, 2026 | -$ 0.43 | -$ 0.53 | -$ 6.31 | |
| Nov 13, 2025 | -$ 0.59 | -$ 0.69 | -$ 2.45 | |
| Aug 7, 2025 | -$ 0.90 | -$ 0.56 | -$ 2.60 | |
| May 6, 2025 | -$ 0.58 | -$ 1.41 | -$ 4.20 | |
| Mar 20, 2025 | -$ 3.13 | -$ 0.67 | -$ 2.50 | |
| Nov 14, 2024 | - | -$ 6.31 | -$ 4.20 | |
| Aug 13, 2024 | - | -$ 2.45 | -$ 4.20 | |
| May 9, 2024 | - | -$ 2.60 | -$ 4.20 | |
| Mar 21, 2024 | -$ 0.23 | -$ 4.20 | -$ 3.80 | |
| Nov 13, 2023 | -$ 0.48 | -$ 2.50 | -$ 5.65 | |
| Aug 11, 2023 | -$ 4.80 | -$ 4.20 | -$ 2.70 | |
| May 9, 2023 | -$ 4.80 | -$ 4.20 | -$ 2.50 | |
| Mar 22, 2023 | -$ 4.70 | -$ 4.20 | -$ 2.61 | |
| Nov 10, 2022 | -$ 5.20 | -$ 3.80 | -$ 2.75 | |
| Aug 15, 2022 | - | -$ 5.65 | $ 0.00 | |
| Aug 9, 2022 | - | -$ 2.70 | -$ 0.75 | |
| Mar 7, 2022 | - | -$ 2.50 | - | - |
Senti Biosciences’s stock was trading at $ 0.1572 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, SNTI’s price decreased to $ 0.14 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | | $ 0.1572 | $ 0.14 | |
| Aug 14, 2026 | -$ 0.41 | $ 0.384 | $ 0.43 | |
| May 14, 2026 | -$ 0.14 | $ 0.963 | $ 1.01 | |
| Mar 27, 2026 | -$ 0.53 | $ 0.8814 | $ 0.7718 | |
| Nov 13, 2025 | -$ 0.69 | $ 1.89 | $ 1.61 | |
| Aug 7, 2025 | -$ 0.56 | $ 1.69 | $ 1.58 | |
| May 6, 2025 | -$ 1.41 | $ 3.28 | $ 3.32 | |
| Mar 20, 2025 | -$ 0.67 | $ 3.62 | $ 3.68 | |
| Nov 14, 2024 | -$ 6.31 | $ 2.25 | $ 2.15 | |
| Aug 13, 2024 | -$ 2.45 | $ 1.78 | $ 2.17 | |
| May 9, 2024 | -$ 2.60 | $ 4.00 | $ 3.69 | |
| Mar 21, 2024 | -$ 4.20 | $ 4.40 | $ 4.39 | |
| Nov 13, 2023 | -$ 2.50 | $ 5.19 | $ 3.50 | |
| Aug 11, 2023 | -$ 4.20 | $ 7.99 | $ 7.86 | |
| May 9, 2023 | -$ 4.20 | $ 10.60 | $ 9.75 | |
| Mar 22, 2023 | -$ 4.20 | $ 12.80 | $ 12.50 | |
| Nov 10, 2022 | -$ 3.80 | $ 22.90 | $ 24.40 | |
| Aug 15, 2022 | -$ 5.65 | $ 21.10 | $ 20.00 | |
| Aug 9, 2022 | -$ 2.70 | $ 22.90 | $ 21.70 | |
| Mar 7, 2022 | -$ 2.50 | $ 98.90 | $ 98.70 |
Senti Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Senti Biosciences beat analysts’ expectations during the last earnings period by
